Posts

Showing posts with the label ivermectin

COVID: potential vaccine and med

blog from 4/6/20 I bring up these 2 snippets since they reflect the fact that there are lots of ongoing research efforts around the SARS-CoV-2 virus, and something is going to work (we live in hope,or at least try to ...).  the first is about an interesting vaccine/delivery system (and is one of many different ongoing vaccine approaches), and the second is about the potential anti- SARS-CoV-2 effect of the old  antiparasitic drug invermectin.  Thanks to Julita Mir and Jon Pincus for sending these along ---------------------------------------------- Vaccine:  There are many different types of vaccines being tried out for SARS-CoV-2 being developed. One interesting one that made it onto NPR involves a microneedle delivery system for a recombinant vaccine, from the University of Pittsburg School of Medicine. See  https://www.pharmaexcipients.com/wp-content/uploads/2020/04/Microneedle-array-delivered-recombinant-coronavirus-vaccines.pdf   Details: -- these rese...

COVID: potential vaccine and med

I bring up these 2 snippets since they reflect the fact that there are lots of ongoing research efforts around the SARS-CoV-2 virus, and something is going to work (we live in hope, or at least try to ...).  the first is about an interesting vaccine/delivery system (and is one of many different ongoing vaccine approaches), and th second is about the potential anti- SARS-CoV-2 effect of the old  antiparasitic drug invermectin.  Thanks to Julita Mir and Jon Pincus for sending these along ---------------------------------------------- Vaccine:   There are many different types of vaccines being tried out for SARS-CoV-2 being developed. One interesting one that made it onto NPR involves a microneedle delivery system for a recombinant vaccine, from the University of Pittsburg School of Medicine. See   https://www.pharmaexcipients.com/wp-content/uploads/2020/04/Microneedle-array-delivered-recombinant-coronavirus-vaccines.pdf Details: -- these rese...